Biocon Limited(NSE:BIOCON)

{{price.price}} INR

{{price.change}}%

：{{price.high}}	：1896911	：3.03%	：3.9705
：{{price.low}}	：694648808	：92.23%	：424
：{{price.open}}	：-1.82%	：2.95%	：291
：{{price.close}}	：-0.12	：57005000000%	：593565912563

-3.68	-9.36	0.55	-7.29
-6.82	-5.02	-13.3	351.31
2.92	3.01	2.57	1896911
18144966	46216185	符号详情：1天涨跌率 -1.82	-3.03
-7.03	-6	-11	-27
372	376	393	3404308.2
2657420.4	3746058.67	3385471.89	0.57
-0.12	-0.3	-0.23	0.57
1.01	0.63	359	358
331	14	291	401
424	424	487	424
8.46	3.97	10133000000	4855000000
14010000000	41551000000	57005000000	1.17
0.63	8.46	3.97	16246000000
152110000000	164758000000
			14076000000
	104320000000	330552000000	174600000000
46011000000	32295000000	61035000000	49270000000
187811000000	310848000000	162542000000	162542000000
165355000000	627598000000	760401912563	8.02

			6.66
2.95	27.32	34.6	4.89
2.03	10.84	9.86

Biocon Ltd. is a holding company, which engages in the manufacture, research, and development of therapeutic drugs. It operates through the following segments: Small Molecules, Biologics, Branded Formulations, and Research Services. The Small Molecules segment manufactures spanning statins, immunosuppressants, antifungals, anti-obesity, anti-diabetics, ophthalmologicals, oncologicals, and urologicals etc. The Biologics segment provides Insulins and Analogs, biosimilar Monoclonal Antibodies (MAbs), and recombinant proteins The Branded Formulation segment consists of therapeutic areas of diabetology, oncology, immunology and critical care. The Research Services segment covers Syngene development platforms. The company was founded by Kiran Mazumdar-Shaw on November 29, 1978 and is headquartered in Bangalore, India.

： http://www.biocon.com

：-

：1978

：Bangalore

：Health technology

：Pharmaceuticals: major